| Splice-modulating oligonucleotide QR-110 restores CEP290 mRNA and function in human c. 2991+ 1655A> G LCA10 models K Dulla, M Aguila, A Lane, K Jovanovic, DA Parfitt, I Schulkens, HL Chan, ... Molecular Therapy-Nucleic Acids 12, 730-740, 2018 | 135 | 2018 |
| Uncoupling of the spindle-checkpoint and chromosome-congression functions of BubR1 S Elowe, K Dulla, A Uldschmid, X Li, Z Dou, EA Nigg Journal of cell science 123 (1), 84-94, 2010 | 132 | 2010 |
| Antisense therapy for a common corneal dystrophy ameliorates TCF4 repeat expansion-mediated toxicity C Zarouchlioti, B Sanchez-Pintado, NJH Tear, P Klein, P Liskova, K Dulla, ... The American Journal of Human Genetics 102 (4), 528-539, 2018 | 73 | 2018 |
| From proteome lists to biological impact–tools and strategies for the analysis of large MS data sets R Malik, K Dulla, EA Nigg, R Körner Proteomics 10 (6), 1270-1283, 2010 | 72 | 2010 |
| The cAMP phosphodiesterase-4D7 (PDE4D7) is downregulated in androgen-independent prostate cancer cells and mediates proliferation by compartmentalising cAMP at the plasma … DJP Henderson, A Byrne, K Dulla, G Jenster, R Hoffmann, GS Baillie, ... British journal of cancer 110 (5), 1278-1287, 2014 | 61 | 2014 |
| Quantitative site-specific phosphorylation dynamics of human protein kinases during mitotic progression K Dulla, H Daub, R Hornberger, EA Nigg, R Körner Molecular & Cellular Proteomics 9 (6), 1167-1181, 2010 | 56 | 2010 |
| Bub1 autophosphorylation feeds back to regulate kinetochore docking and promote localized substrate phosphorylation A Asghar, A Lajeunesse, K Dulla, G Combes, P Thebault, EA Nigg, ... Nature communications 6 (1), 8364, 2015 | 34 | 2015 |
| Human phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG-positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease … R Böttcher, DJP Henderson, K Dulla, D van Strijp, LF Waanders, G Tevz, ... British Journal of Cancer 113 (10), 1502-1511, 2015 | 30 | 2015 |
| Human PDE4D isoform composition is deregulated in primary prostate cancer and indicative for disease progression and development of distant metastases R Böttcher, K Dulla, D van Strijp, N Dits, EI Verhoef, GS Baillie, ... Oncotarget 7 (43), 70669, 2016 | 26 | 2016 |
| Assessment of cellular signaling pathway activity using probabilistic modeling of target gene expression WFJ Verhaegh, A Van De Stolpe, HJ Van Ooijen, KC Dulla, MA De Inda, ... US Patent 11,443,831, 2022 | 19 | 2022 |
| Transcriptome analysis of the distal small intestine of Cftr null mice PT Ikpa, KF Meijsen, NDA Nieuwenhuijze, K Dulla, HR de Jonge, ... Genomics 112 (2), 1139-1150, 2020 | 18 | 2020 |
| Large-scale mitotic cell synchronization K Dulla, A Santamaria Cell Cycle Synchronization: Methods and Protocols, 65-74, 2011 | 8 | 2011 |
| Pro-inflammatory cytokines stimulate CFTR-dependent anion secretion in pancreatic ductal epithelium D Angyal, TA Groeneweg, A Leung, M Desain, K Dulla, HR de Jonge, ... Cellular & Molecular Biology Letters 29 (1), 18, 2024 | | 2024 |
| Assessment of cellular signaling pathway activity using probabilistic modeling of target gene expression WFJ Verhaegh, A Van De Stolpe, HJ Van Ooijen, KC Dulla, MA De Inda, ... US Patent App. 17/821,839, 2023 | | 2023 |
| Solun signalointireitin aktiivisuuden arviointi kohdegeenin ekspression probabilistisen mallinnuksen avulla WFJ Verhaegh, OHJ Van, KC Dulla, RD Hoffmann | | 2022 |
| ASSESSMENT OF THE ACTIVITY OF A CELLULAR SIGNAL ROUTE USING PROBALISTIC MODELING OF TARGET EXPRESSION WFJ Verhaegh, OHJ Van, KC Dulla, R Hoffmann | | 2018 |
| Evaluación de la actividad de la ruta de señalización celular utilizando un modelo probabilístico de la expresión del gen objetivo WFJ Verhaegh, A Van De Stolpe, HJ VAN OOIJEN, KC DULLA, ... | | 2017 |
| EVALUATION OF CELL SIGNALING VACANCY WITH USING PROBABILIST MODELING TARGET EXPRESSION WFJ Verhaegh, OHJ Van, KC Dulla, R Hoffmann | | 2017 |
| Identifying tumor driving signaling pathways for companion diagnostics using computational pathway models. W Verhaegh, H van Ooijen, M Alves de Inda, K Dulla, R Hoffmann, ... Cancer Research 73 (8_Supplement), 59-59, 2013 | | 2013 |
Roman KörnerGroup Leader Mass Spectrometry, Max Planck Institute of BiochemistryVerified email at biochem.mpg.de
